Senokot-S (sennosides 8.6 mg docusate sodium 50 mg) Dailymed
Generic: standardized senna concentrate and docusate sodium is used for the treatment of Colic Constipation Intestinal Obstruction Nausea Vomiting Abdominal Pain
All Imprints
senokot-s (standardized senna concentrate and docusate sodium) tablet - p round orange
Go PRO for all pill images
Indications & Usage Section
Drug Facts
Otc - Active Ingredient Section
Active ingredients (in each tablet)
Docusate sodiumβββββββββ50mg
Sennosidesββββββββββββββββββββββ8.6mg
Otc - Purpose Section
Purpose
Stool softener
Laxative
Otc - When Using Section
Uses
- relieves occasional constipation (irregularity)
- generally produces a bowel movement in 6-12 hours
Warnings Section
Warnings
Otc - Do Not Use Section
Do not use
- if you are now taking mineral oil, unless directed by adoctor
- laxative products for longer than 1 week unless directedby a doctor
Otc - Ask Doctor Section
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that continues overa period of 2 weeks
Otc - Stop Use Section
Stop using and ask a doctor if youhave rectal bleeding or fail to have a bowel movement after use ofa laxative. These may indicate a serious condition.
Otc - Pregnancy Or Breast Feeding Section
If pregnant or breast-feeding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children Section
Keep out of reachof children.
In case ofoverdose, get medical help or contact a Poison Control Center rightaway.
Dosage & Administration Section
Directions
- take preferably at bedtime or as directed by a doctor
age startingdosage maximumdosage adults and children12 years of age and over 2 tablets oncea day 4 tablets twicea day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
How Supplied Section
Other information
- each tablet contains: calcium 7 mg, sodium 4 mg VERYLOW SODIUM
- store at 25Β°C (77Β°F); excursions permitted between 15Β°-30Β°C(59Β°-86Β°F)
Inactive Ingredient Section
Inactive ingredients
Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Yellow#5 Lake*, FD&C Yellow #6 Lake, hypromellose, magnesium stearate,maltodextrin, microcrystalline cellulose, mineral oil, polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, starch, stearic acid,talc, titanium dioxide, triacetin
Β©2020
Avrio Health L.P.
A1023
Package Label.principal Display Panel
Senokot-S 60 Tablets LabelNDC: 67618-310-60
Senokot-S 60 Tablets LeafletNDC: 67618-310-60
Senokot-S 60 Tablets CartonNDC: 67618-310-60
Senokot-S 10 Tablets CartonNDC: 67618-310-01
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
